UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

The lancet oncology, 2015-06, Vol.16 (6), p.645-655

2015

Volltextzugriff (PDF)

Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome

Cardiovascular and interventional radiology, 2022-02, Vol.45 (2), p.172-181

2022

Volltextzugriff (PDF)

Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization

Radiology, 2014-02, Vol.270 (2), p.607

2014

Volltextzugriff (PDF)

Targeting tumor hypoxia in nasopharyngeal carcinoma

Head & neck, 2013-01, Vol.35 (1), p.133-145

2013

Volltextzugriff (PDF)

CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma

The American journal of pathology, 2012-03, Vol.180 (3), p.1215-1222

2012

Volltextzugriff (PDF)

Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes

Journal of vascular and interventional radiology, 2016-05, Vol.27 (5), p.639-649

2016

Volltextzugriff (PDF)

Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients

Clinical cancer research, 2009-02, Vol.15 (3), p.1005-1012

2009

Volltextzugriff (PDF)

STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro

International journal of cancer, 2009-10, Vol.125 (8), p.1884-1893

2009

Volltextzugriff (PDF)

Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic

American Society of Clinical Oncology educational book, 2014 (34), p.149-153

2014

Volltextzugriff (PDF)

Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry

Oncology reports, 2008-07, Vol.20 (1), p.89-98

2008

Volltextzugriff (PDF)

Immunoglobulin therapy and passive transfer of anti-HBc: too often forgotten

The Lancet. Haematology, 2018-10, Vol.5 (10), p.e437-e438

Hui, Edwin Pun

2018

Volltextzugriff (PDF)

Phase II study of TAS‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer

Cancer medicine (Malden, MA), 2013-06, Vol.2 (3), p.351-359

2013

Volltextzugriff (PDF)

Antitumor Effect and Enhancement of Cytotoxic Drug Activity by Cetuximab in Nasopharyngeal Carcinoma Cells

In vivo (Athens), 2005-01, Vol.19 (1), p.237

2005

Volltextzugriff (PDF)

Abstract 948: Preclinical evaluation of VEGF Ang2 bispecific nanobody BI836880 in patient-derived xenograft models of nasopharyngeal carcinoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.948-948

2021

Volltextzugriff (PDF)

Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

The lancet oncology, 2023-06, Vol.24 (6), p.611-623

2023

Volltextzugriff (PDF)

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Current opinion in oncology, 2020-05, Vol.32 (3), p.187

2020

Volltextzugriff (PDF)

Complete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinoma

Rare tumors, 2009-07, Vol.1 (1), p.e7-e7

2009

Volltextzugriff (PDF)

Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer

Clinical cancer research, 2021-05, Vol.27 (10), p.2827-2836

2021

Volltextzugriff (PDF)

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

JNCI : Journal of the National Cancer Institute, 2017-04, Vol.109 (4)

2017

Volltextzugriff (PDF)

Isolated Tumor Cells and Circulating CK20 mRNA in pN0 Colorectal Cancer Patients

International journal of surgical pathology, 2008-04, Vol.16 (2), p.119-126

2008

Volltextzugriff (PDF)

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients

Clinical and translational radiation oncology, 2022-01, Vol.32, p.59-68

2022

Volltextzugriff (PDF)

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6002-6002

2017

Volltextzugriff (PDF)

Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC)

American journal of cancer research, 2015-01, Vol.5 (4), p.1496-1506

2015

Volltextzugriff (PDF)

A phase II clinical trial on combined axitinib and transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): Final results and evaluation of clinical predictor for response

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4073-4073

2015

Volltextzugriff (PDF)

A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6031-6031

2015

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Berichte
(1)

Sprache

Englisch
(40)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(24)
Humans
(21)
Oncology
(14)
Nasopharyngeal Carcinoma
(9)
Nasopharyngeal Neoplasms - Drug Therapy
(8)
Female
(7)
Chemotherapy
(6)
Male
(6)
Treatment Outcome
(6)
Tumors
(6)
Carcinoma
(5)
Cell Line, Tumor
(5)
Middle Aged
(5)
Nasopharyngeal Neoplasms - Pathology
(5)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Aged
(4)
Biological And Medical Sciences
(4)
Disease-Free Survival
(4)
Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome

Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization

Targeting tumor hypoxia in nasopharyngeal carcinoma

CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma

Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes

Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients

STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro

Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic

Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry

Immunoglobulin therapy and passive transfer of anti-HBc: too often forgotten

Phase II study of TAS‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer

Antitumor Effect and Enhancement of Cytotoxic Drug Activity by Cetuximab in Nasopharyngeal Carcinoma Cells

Abstract 948: Preclinical evaluation of VEGF Ang2 bispecific nanobody BI836880 in patient-derived xenograft models of nasopharyngeal carcinoma

Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Complete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinoma

Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

Isolated Tumor Cells and Circulating CK20 mRNA in pN0 Colorectal Cancer Patients

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC)

A phase II clinical trial on combined axitinib and transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): Final results and evaluation of clinical predictor for response

A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC)

Suchergebnisse filtern